SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K was filed on January 17, 2023, by BioSig Technologies, Inc. (BSGM), a company listed on The NASDAQ Capital Market. The filing addresses a regulatory event concerning the company's compliance with Nasdaq listing standards.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric referenced is the Stockholders' Equity Requirement of $2,500,000, which the company failed to maintain as of November 22, 2022.
Material Changes and Events
- Non-Compliance Notification: On November 22, 2022, Nasdaq notified the company of its failure to meet the minimum $2,500,000 stockholders' equity requirement and alternative compliance standards (market value of listed securities or net income).
- Compliance Extension Granted: On January 17, 2023, Nasdaq granted the company an additional 180-day period to regain compliance, extending the deadline to May 22, 2023.
Outlook, Risks, and Contingencies
The company faces a significant risk of delisting if it cannot demonstrate compliance with the Stockholders' Equity Requirement by the time it files its periodic report for the period ending June 30, 2023. Management explicitly states there can be no assurance that the company will regain compliance or maintain its listing on the Nasdaq Stock Market.
Investor Verification Checklist
- Verify the company's current stockholders' equity balance in the most recent 10-Q or 10-K.
- Monitor the company's progress toward the May 22, 2023 compliance deadline.
- Review the upcoming periodic report for the period ending June 30, 2023, to confirm if delisting proceedings are initiated.
- Assess the company's capital raise plans or operational changes intended to restore equity levels.